The Quality of Life of Mothers of Children With Food Allergy
The Effects of Nutritional Counseling on Maternal Quality of Life of Children With Food Allergy
1 other identifier
interventional
100
1 country
1
Brief Summary
Food allergy (FA) derives from an abnormal immunological response to dietary antigens. On the basis of the immunological mechanism, FA are divided into the following forms: IgE-mediated, non-IgE-mediated and mixed. Prevalence, persistence and severity of pediatric FA have significantly increased over the past 2 decades. The treatment of FA is based on a rigorous elimination diet and on the correct management of acute allergic reactions, induced by the accidental ingestion of food allergens, with antihistamines, cortisones and adrenaline. Ensuring a strict exclusion of the allergen from the diet can be problematic, with the risk of nutritional deficiencies, accidental exposure, cross-contamination or caused by incorrect labeling of processed food products. At the same time, the daily management of a correct elimination diet and a possible allergic reaction, entail a significant burden and high levels of anxiety and stress associated with uncertainty about the management of anaphylaxis, in the parents of children with FA, particularly in mothers, resulting in an impact on Quality of Life (QoL). The availability of a multidisciplinary team made up of pediatricians, allergists and dietitians / nutritionists with experience in the field of FA could reduce the stress and anxiety of parents, while improving their QoL. Currently, for the evaluation of the quality of life of the parent of a child with FA, specific questionnaires for food allergies developed and validated in English are used: the food allergy self-efficacy scale for parents (FASE-P) and the Food Allergy Quality of Life - Parental Burden Questionnaire (FAQL-PB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedStudy Start
First participant enrolled
January 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2023
CompletedSeptember 29, 2022
September 1, 2022
5 months
February 2, 2021
September 27, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
FASE-P diagnosed by a multidisciplinary team (Group 1) or diagnosed by a non-multidisciplinary team (Group 2).
To explore potential differences at baseline (T0) in the quality of life, provided by the FASE-P questionnaire, of mothers of children with food allergy diagnosed by a multidisciplinary team already followed for at least 6 months by the Tertiary Center of Pediatric Allergology (University Federico II) (Group 1) and of mothers of children with food allergy diagnosed for at least 6 months (by a non-multisciplinary team) who plan to visit for the first time the same Center (Group 2).
baseline
FAQL-PB
To explore potential differences at baseline (T0) in the quality of life, provided by the FAQL-PB questionnaire, of mothers of children with food allergy diagnosed by a multidisciplinary team already followed for at least 6 months by the Tertiary Center of Pediatric Allergology (University Federico II) (Group 1) and of mothers of children with food allergy diagnosed for at least 6 months (by a non-multisciplinary team) who plan to visit for the first time the same Center (Group 2).
baseline
FAQLQ-PF
To explore potential differences at baseline (T0) in the quality of life, provided by the FAQLQ-PF questionnaire, of mothers of children with food allergy diagnosed by a multidisciplinary team already followed for at least 6 months by the Tertiary Center of Pediatric Allergology (University Federico II) (Group 1) and of mothers of children with food allergy diagnosed for at least 6 months (by a non-multisciplinary team) who plan to visit for the first time the same Center (Group 2).
baseline
Secondary Outcomes (12)
FASE-P Group 2
6 months
FAQL-PB Group 2
6 months
FAQLQ-PF Group 2
6 months
FASE-P at 6 months Group 2 versus Group 1
6 months
FAQL-PB Group 2 versus Group 1
6 months
- +7 more secondary outcomes
Study Arms (2)
Mothers of children with food allergy diagnosed by a multidisciplinary team
NO INTERVENTIONMothers of children with food allergy diagnosed by a multidisciplinary team (Group 1) already followed for at least 6 months by the Tertiary Center of Pediatric Allergology..
Mothers of children with food allergy diagnosed by a non-multidisciplinary team
EXPERIMENTALMothers of children with food allergy diagnosed by a non-multidisciplinary team who plan to visit for the first time the Tertiary Center of Pediatric Allergology.
Interventions
Active diet therapy, instructions on reading labels, cross-contamination, allergen-free, foods recipes
Eligibility Criteria
You may qualify if:
- Adult mother of a patient \<12 years of age diagnosed with FA
You may not qualify if:
- Mother's age \<18 years
- Mother unable to understand Italian
- Mother suffering from chronic diseases
- Mother suffering from epilepsy
- Mother suffering from neoplasms
- Mother suffering from immunodeficiencies
- Mother suffering from chronic infections
- Mother suffering from autoimmune diseases
- Mother suffering from inflammatory bowel diseases
- Mother suffering from functional gastrointestinal disorders
- Mother suffering from celiac disease
- Mother suffering from genetic-metabolic diseases
- Mother suffering from tuberculosis
- Mother suffering from congenital heart disease
- Mother suffering from tuberculosis
- +29 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Traslational Medical Science - University of Naples Federico II
Naples, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor- Chief of the Pediatric Allergy Program at the Department of Traslational Medical Science
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 5, 2021
Study Start
January 10, 2022
Primary Completion
June 10, 2022
Study Completion
January 10, 2023
Last Updated
September 29, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share